Definium Therapeutics, Inc.
DFTX
Revenue
0.00
0.000.00%
-Assets
440.10M
▲203.18M▲85.76%
3 Months ChangeLiabilities
107.77M
▲1.45M▲1.37%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-02-26
Form 8-K
ID: 0001193125-26-076612
2026-01-29
Form 8-K
ID: 0001193125-26-028186
2026-01-12
Form 8-K
ID: 0001193125-26-009854
2025-11-06
Form 10-Q
ID: 0001193125-25-269596
2025-11-06
Form 8-K
ID: 0001193125-25-269548
2025-10-31
Form 8-K
ID: 0001104659-25-104696
2025-10-29
Form 8-K
ID: 0001104659-25-103726
2025-09-04
Form 8-K
ID: 0000950170-25-112973
2025-07-31
Form 10-Q
ID: 0000950170-25-100925
2025-07-31
Form 8-K
ID: 0000950170-25-100902